Kalaris Therapeutics, Inc. · NASDAQ:KLRS

Kalaris Therapeutics, Inc. shareholders

As of Sep 30, 2026, 52 institutions reported holding Kalaris Therapeutics, Inc., 72.4% of its shares. Largest: Samsara Biocapital, LLC, Rtw Investments, LP and Alyeska Investment Group, L.P. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Kalaris Therapeutics, Inc.ChangeFiled
Samsara Biocapital, LLC12.9M54.1%no changeNov 16, 2026
Rtw Investments, LP1.3M5.5%no changeNov 16, 2026
Alyeska Investment Group, L.P.473K2.0%−100KNov 16, 2026
Vanguard379K1.6%−86,410Nov 13, 2026
Siren, L.L.C.357K1.5%−79,239Nov 12, 2026
Ikarian Capital, LLC248K1.0%−112KNov 16, 2026
Renaissance Technologies177K0.74%+27,512Nov 12, 2026
Verdad Advisers, LP140K0.59%+59,935Nov 16, 2026
UBS110K0.46%−152KNov 10, 2026
Raymond James Financial Inc101K0.43%+4,332Nov 12, 2026

Kalaris Therapeutics, Inc. insider trades